| Literature DB >> 30524670 |
Hannaneh Safiaghdam1,2, Vahideh Oveissi3, Roodabeh Bahramsoltani4, Mohammad Hosein Farzaei5, Roja Rahimi4.
Abstract
OBJECTIVES: Periodontal diseases are among prevalent oral health problems which may ultimately lead to severe complications in oral cavity. Herbal products can be designed as single or multicomponent preparations for better oral health. This study aims to review current clinical trials on the effectiveness of herbal products in gingivitis.Entities:
Keywords: Gingivitis; Medicinal plants; Oral diseases; Phytochemicals; Traditional medicine
Year: 2018 PMID: 30524670 PMCID: PMC6281068 DOI: 10.22038/IJBMS.2018.31997.7690
Source DB: PubMed Journal: Iran J Basic Med Sci ISSN: 2008-3866 Impact factor: 2.699
Clinical trials on the use of single medicinal plants for the treatment of gingivitis
| Plant scientific name | Type of preparation | Study design | Jadad score | Duration of study (day) | Outcomes | Reference |
|---|---|---|---|---|---|---|
|
| Dentifrice | Randomized, double-blind, crossover controlled trial in 60 subjects with gingivitis-compared to regular toothpaste | 3 | 28 | ↓GI, QHI, BOP: better with test | ( |
|
| Dentifrice | Randomized clinical trial in 45 subjects-group 1 (scaling)/ group 2 (scaling + | 3 | 42 | ↓PI, GI, PoB, PPD in all groups with best effect in group 2 | ( |
|
| Dentifrice | Randomized, placebo & positively controlled clinical trial in 90 subjects with chronic generalized gingivitis-compared with dentifrice containing fluoride + triclosan | 5 | 168 | ↓GI, QHI, microbial count same in both groups | ( |
|
| Mouthwash | Single-center, single-blind, controlled trial in 85 subjects- compared to CHX or chlorine dioxide | 3 | 15 | ↓PI, GI with better effect by CHX and chlorine | ( |
|
| Mouthwash | Randomized, double-blind, controlled study in 120 healthy subjects with experimental gingivitis -compared with CHX | 2 | 22 | ↓BI, MGI, PI in both groups (CHX was better in PI) | ( |
|
| Mouthwash | Controlled clinical trial in 45 subjects with plaque-induced gingivitis in comparison to scaling only | 2 | 90 | ↓GI & SBI | ( |
|
| Dentifrice | Randomized, double-blind, intra-individual & controlled clinical study in 15 subjects with gingivitis-compared with control dentifrice | 4 | 1.5 year | ↓PI, GI same in both groups | ( |
|
| Dentifrice | Randomized, double-blind, parallel, clinical trial in 30 subjects- compared with fluoridated dentifrice | 4 | 30 | ↓PI, GBI same in both groups | ( |
|
| Mouthwash | Randomized, triple-blind, controlled trial in 345 subjects- compared with CHX | 5 | 30 | ↓PI, GI same in both groups | ( |
|
| Mouthwash | Double-blind clinical trial in 80 subjects with gingivitis- compared with CHX and povidone iodine | 5 | 14 | ↓PI, GI | ( |
|
| Mouthwash | Randomized, double-blind, controlled trial in 45 subjects with plaque induced gingivitis-compared with CHX | 2 | 28 | ↓BI, GI, BOP | ( |
|
| Mouthwash | Clinical trial in 97 subjects with gingivitis-compared with CHX | 5 | 21 | ↓PI | ( |
|
| Gel | Double-blind clinical trial in 45 subjects-compared with Colgate anti-plaque dentifrice | 1 | 21 | ↓PI, GI same in both groups | ( |
|
| Gum | Randomized, double-blind, placebo-controlled trial in 75 subjects with moderate plaque-induced gingivitis | 3 | 14 | ↓PI, GI, PPD, BI with no significant difference between extract & powder | ( |
|
| Mouthwash | Placebo-controlled, clinical trial in 240 subjects with gingivitis | 3 | 180 | ↓PI,GI,SBI,OHIS | ( |
|
| Dentifrice | Double-blind, clinical trial in 40 subjects with established gingivitis-compared with placebo | 4 | 28 | ↓PI, GI & BOP | ( |
|
| Sugar-free dragées | Placebo-controlled, double-blind clinical trial in 47 subjects | 3 | 28 | ↓SBI, API | ( |
|
| Mouthwash | Clinical trial in 30 subjects- compared with CHX | 2 | 30 | ↓QHI, GBI, tooth stain, & tongue stain same in both groups | ( |
|
| Mouthwash | Single blind crossover clinical trial in 30 subjects- compared with CHX | 3 | 15 | ↓PI | ( |
|
| Hydroxy-propyl-cellulose strips as a slow release local delivery system applied in pockets | Randomized, placebo-controlled clinical trial in 6 subjects with advanced periodontitis –group1 (scaling + tea) /group 2 (scaling + placebo) /group3 (tea only) /group 4 (placebo) | 1 | 56 |
| ( |
|
| Mouthwash | Randomized, double-blind, clinical trial in 30 healthy subjects- compared with CHX | 5 | 21 | ↓GI | ( |
|
| Mouthwash | Randomized, placebo-controlled clinical trial in 110 subjects | 5 | 28 | ↓GI, PI | ( |
|
| Mouthwash | Single-blind, placebo-controlled, clinical trial in 50 subjects with chronic generalized plaque-induced gingivitis | 1 | 35 | ↓PI, GI, PBI | ( |
|
| Mouthwash | Randomized, triple-blind, controlled trial, a three-group parallel study in 105 subjects- compared with CHX | 4 | 30 | ↓GI, QHI | ( |
|
| Gel | Randomized placebo-controlled clinical trial in 23 subjects with experimental gingivitis | 5 | 21 | ↓GBI, GI, PI compared with basline but no significant difference between groups | ( |
|
| Mouthwash | Clinical trial in 100 subjects- compared with CHX | 3 | 21 | ↓GI & total microbial count: | ( |
|
| Gel | Uncontrolled pilot clinical trial in 10 subjects with severe gingivitis | 1 | 21 | ↓PBI,GI | ( |
|
| Mouthwash | Clinical trial in 60 subjects with mild to moderate gingivitis-compared with CHX | 0 | 21 | ↓GI, PI, BAPNA | ( |
| Curcumin (from | Gel | Randomized, double-blind clinical trial in 60 subjects- compared to CHX 10 mg & CHX-MTZ 10 mg | 5 | 60 | MGI, PI, BOP, PPD: no significant change | ( |
| Curcumin (from | Gel | Randomized clinical trial in 30 subject with severe gingivitis- compared with curcumin + SRP treatment | 2 | 21 | ↓SBI, PI, GI | ( |
|
| Mouthwash | Randomized, double-blind, controlled parallel designed clinical trial in 60 subjects-compared with CHX | 5 | 21 | ↓PI, GI and | ( |
|
| Mouthwash | Randomized, double-blind, controlled trial in 55 subjects – compared with Listerine | 2 | 42 | ↓GI, QHI, GBI, bacterial strains ( | ( |
|
| Chewing gum | Randomized, double-blind, placebo-controlled, trial in 97 subjects with gingivitis | 4 | 98 | ↓GI, PPD, BOP, plaque accumulation | ( |
| Eugenia uniflora 3% | Dentifrice | Randomized, double-blind, controlled clinical trial in 50 subjects–compared with fluoridated triclosan dentifrice | 5 | 7 | ↓OHI only in control | ( |
|
| Gel | Controlled clinical trial in 31 subjects with periodontal pocket- compared with scaling only | 2 | 90 | ↓BOP, PI, GI, PPD, clinical attachment, means percentage of | ( |
|
| Mouthwash | Randomized, placebo-controlled clinical trial in 20 subjects | 0 | 14 | ↓PI, GI | ( |
|
| Dentifrice | Randomized, double-blind, placebo-controlled clinical trial in 100 subjects-compared with normal dentifrice without active agents | 5 | 84 | ↓GI,QHI | ( |
|
| Mouthwash | Randomized, controlled clinical trial in 20 subjects- compared with CHX | 2 | 28 | ↓GI, QHI, BOP: same in both groups | ( |
|
| Daily consumption (systemic administration) | Randomized, double-blind, placebo-controlled clinical trial in 39 subjects with chronic gingivitis | 5 | 14 | No significant change in PCR | ( |
|
| Mouthwash | Randomized, double-blind, parallel-armed pilot study in 55 subjects- compared with CHX | 4 | 7 | ↓GI, PI, GBI | ( |
|
| Mouthwash | Randomized, double-blind, parallel-armed pilot study in 55 subjects- compared with CHX | 4 | 7 | ↓GI, GBI, PI, salivary | ( |
|
| Gel | Parallel controlled clinical trial in 30 subjects- compared with CHX | 5 | 90 | ↓PI, GBI | ( |
|
| Gel | Randomized, double-blind, placebo-controlled, crossover clinical trial in 22 subjects with experimental gingivitis | 4 | 21 | ↓GI | ( |
|
| Dentifrice | Double-blind, placebo-controlled, clinical trial in 40 subjects with gingivitis | 2 | 84 | ↓PI | ( |
|
| Chewing gum | Randomized, double-blind, controlled intervention trial in 117 subjects-compared with xylitol chewing gum or placebo chewing gum | 5 | 30 | Plaque pH | ( |
|
| Dentifrice | Randomized, double-blind, placebo-controlled clinical trial in 94 subjects | 5 | 180 | ↓QHI,GI | ( |
|
| Mouthwash | Randomized, double-blind, placebo-controlled pilot study in 30 subjects- compared with CHX | 4 | 15 | ↓VPI, GBI | ( |
|
| Gel | Double-blind, longitudinal, non-crossover study in 49 subjects with severe chronic gingivitis-compared with CHX | 3 | 56 | GI: CHX>test > control | ( |
|
| Mouthwash | Double-blind, crossover, controlled clinical trial in 30 subjects-compared with CHX 0.2% & deionized water | 1 | 5 | ↓PI, GI, GBI | ( |
|
| Mouthwash | Randomized, parallel, double-blind clinical trial in 30 subjects-compared with CHX | 5 | 90 | ↓PI, GBI | ( |
|
| Mouthwash | Randomized, triple blind, controlled trial in 108 subjects- compared with CHX | 5 | 30 | ↓PI, GI same in both groups | ( |
|
| Mouthwash | Uncontrolled clinical trial in 51 subjects with gingivitis | 1 | 14 | ↑PI (however, the consistency of this plaque permitted its mechanical flushing easily) | ( |
|
| Mouthwash | Randomized, double-blind, placebo-controlled clinical trial in 104 subjects with gingivitis | 2 | 28 | ↓PI, | ( |
|
| Gel | Placebo-controlled, crossover, double-blind study in 23 subjects | 4 | 21 | No significant change in PI, GBI | ( |
|
| Mouthwash | Randomized, controlled, double-blind clinical trial in 35 subjects-compared with CHX | 4 | 7, 12 | ↓GBI, PI | ( |
|
| Gel | Clinical trial in 40 subjects- group 1(mechanical debridement + test gel)/ group 2 (mechanical debridement + control gel)/ group 3 (test gel only)/ group 4 (control gel only) | 2 | 21 | ↓PI, GI, PBI in groups 1 & 2 but not in groups 3 & 4 | ( |
|
| Mouthwash | Randomized, single-blind, placebo-controlled clinical trial in 32 subjects with moderate gingivitis | 1 | 28 | ↓Saliva total protein, AST activity & α-glucosidase activity | ( |
|
| Mouthwash | Randomized, triple-blind, placebo-controlled clinical trial in 45 subjects- compared with CHX | 5 | 4 | ↓GI with best effect by | ( |
|
| Mouthwash | Randomized, double-blind, clinical trial in 80 subjects with diabetes mellitus & gingivitis- compared with CHX | 5 | 14 | ↓GBI, PPD, PI same in both groups | ( |
|
| Drop pill or tablets of simulation agent | Randomized, double-blind, double-simulation, positive-controlled parallel multi-center trial in 136 subjects with gingivitis | 4 | 5 | ↓Major symptoms of Gingivitis | ( |
|
| Miswak (chewing stick) | Randomized, single-blind, parallel-armed study in 30 subjects with mild to moderate gingivitis -group 1 (only toothbrush)/ group 2 (toothbrush+ Miswak)/ group 3 (only Miswak) | 1 | 56 | ↓GI: Group 2 > group 1 = group 3 | ( |
|
| Miswak (chewing stick) | Randomized, double-blind, controlled trial in 58 subjects with gingivitis | 5 | 21 | ↓API & GI: | ( |
|
| Gum | Randomized, placebo-controlled clinical trial in 60 subjects with plaque induced moderate gingivitis- Either combined with SRP treatments or solely | 4 | 14 | ↓GI, SBI | ( |
|
| Mouthwash | Randomized, placebo-controlled, clinical trial in 32 subjects with gingivitis-compared with CHX | 1 | 14 | ↓CFU of plaque samples: CHX> | ( |
|
| Mouthwash | Double-blind, placebo-controlled, crossover trial in 28 subjects | 2 | 21 | No significant change in PI | ( |
|
| Dentifrice | Controlled, clinical trial in 66 non-smoking subjects -compared with Colgate total | 3 | 21 | ↓SBI: Parodontax = | ( |
|
| Mouthwash | Randomized, double-blind controlled clinical trial in 76 patients under mechanical ventilation in ICU ward- compared with CHX | 3 | 4 | ↓GI | ( |
|
| Mouthwash | Randomized, controlled, triple-blind, phase II clinical trial in 27 subjects with plaque induced gingivitis- compared with CHX | 5 | 10 | ↓OHIS (amount of biofilm) only in CHX | ( |
|
| Dentifrice | Randomized, double-blind clinical trial in 40 subjects with experimental gingivitis-compared with fluoride toothpaste | 5 | 21 | PI, GI, VF% | ( |
|
| Mouthwash | Single-blind, crossover clinical study in 30 subjects-compared with distilled water | 2 | 4 | ↓GI | ( |
|
| Mouthwash | Randomized, double-blind, controlled study in 78 subjects with gingivitis- compared with CHX | 4 | 14 | ↓QHI, GI, pH | ( |
|
| Mouthwash | Randomized, double-blind, controlled trial in 60 subjects- compared with CHX | 5 | 28 | ↓GI, PI | ( |
|
| Daily oral consumption | Placebo-controlled clinical trial in 24 subjects with gingivitis- compared with standard care (debridement) | 2 | 7 | ↓BOP in standard care, 2 & placebo, but not 1 | ( |
GI: Loe & Silness gingival index; SBI: Muhlemann & Son's Sulcus bleeding index; PI: plaque index; PBI: papillary bleeding index; PHPI: Patient Hygiene Performance Index; CPITN: community periodontal index of treatment needs; BOP: Bleeding on probing; GBI: Gingival Bleeding index; VF%: biofilm vitality; API: approximal plaque index; OHIS: simplified Greene & Vermillion’s Oral Hygiene Index; BAPNA: The N-benzoyl-l-arginine-p-nitroanilide (BAPNA) assay used to analyze trypsin like activity of "red" complex microorganisms; CHX: chlorhexidine; QHI: Quigley & Hein plaque index; MGI: modified gingival index; PPD: probing pocket depth; MMP-8: matrix metalloproteinase-8;BA: biofilm accumulation; SAnB: anaerobic (SAnB) & aerobic (SAB) bacterial counts; NPI: Navy Plaque Index; PPI: planimetric plaque index; VPI: visible plaque index; PPBI: The periodontal probe bleeding index of Ainamo & Bay; PSS: plaque staining score; SBI: sulcus bleeding index; PSS: plaque staining score; LB: Lobene index; Parodontax: chamomile, echinacea, sage, rhatany, myrrh & peppermint oil; SRP: Scaling and Root Planing; PHP: patient hygiene performance; PMA: Proximal Marginal and attached gingival index; SNL: Salivary Nitrate Level; MTZ: metronidazole, IL: interleukin, IFN: interferon
Clinical trials on the effectiveness of polyherbal formulations for the treatment of gingivitis
| Arimedadi oil | Mouthwash | Clinical trial in 45 subjects with mild to moderate gingivitis- compared with CHX | 3 | 21 | ↓GI, PI same in both groups | ( |
| Essential oil mixture (thymol, eugenol and eucalyptus) | Dentifrice | Placebo-controlled double-blind, parallel, clinical study in 104 subjects | 3 | 180 | ↓QHI,GI | ( |
| Listerine | Mouthwash | Randomized, placebo-controlled, clinical trial in 32 subjects with gingivitis-compared with CHX | 1 | 14 | ↓CFU of plaque samples: CHX> Listerine | ( |
| Parodontax | Dentifrice | Randomized, double-blind clinical trial in 30 subjects-compared with standard fluoridated dentifrice | 4 | 21 | No significant change in QHI | ( |
| Polyherbal preparation | Dentifrice | Randomized, double-blind, placebo-controlled clinical trial in 66 subjects | 5 | 168 | ↓BOP, PPD, SAnB, QHI | ( |
| Polyherbal preparation | Dentifrice | Randomized, double-blind, placebo-controlled clinical trial in 60 subjects | 4 | 84 | ↓GI, BOP, SAnB | ( |
| Polyherbal preparation | Gel & powder | Randomized, double-blind, placebo-controlled, clinical trial in 113 subjects with chronic generalized gingivitis -compared with CHX | 5 | 168 | ↓GI, PI, microbial count | ( |
| Polyherbal preparation | Mouthwash | A Randomized, double-blind, placebo-controlled clinical trial in 17 subjects with gingivitis | 5 | 84 | No significant difference in PI, GI & | ( |
| Polyherbal preparation | Mouthwash | Randomized, double-blind, placebo-controlled trial in 60 subjects with gingivitis-compared with CHX | 3 | 14 | ↓QHI, MGI, GBI | ( |
| Polyherbal preparation | Mouthwash | Clinical study | 1 | Phase I: | Phase I | ( |
| Polyherbal preparation | Mouthwash + sub-gingival irrigator | Randomized, double-blind clinical study in 89 subjects-group1(irrigator + test mouthwash)/group 2 (irrigator+ conventional mouthwash)/group 3(conventional mouthwash only) | 3 | 90 | ↓GI in group 2, group 1, but not in group 3 | ( |
| Polyherbal preparation | Transmucosal herbal periodontal patch | Randomized, single-center, double-blind placebo-controlled, crossover, longitudinal phase II trial in 50 subjects with gingivitis | 3 | 15 | ↓GI | ( |
| Triphala ( | Mouthwash | Randomized ,double-blind, multicenter clinical trial in 120 hospitalized periodontal disease subjects-compared with CHX | 5 | 15 | ↓PI, GI same in both groups | ( |
| Triphala 0.6% ( | Mouthwash | Controlled clinical trial in 1431 healthy subjects -compared with CHX and placebo | 3 | 270 | ↓PI, GI, | ( |
| Triphala 10% ( | Mouthwash | Randomized, double-blind, crossover study in 120 healthy subjects- compared with CHX | 5 | 30 | ↓QHI, GI same in both groups | ( |
GI: Loe & Silness gingival index; SBI: Muhlemann & Son's Sulcus bleeding index; PI: plaque index; PBI: papillary bleeding index; CHX: chlorhexidine; QHI: Quigley & Hein plaque index; PPD: probing pocket depth; SAnB: anaerobic bacterial count
Figure 1Medicinal plants, active components, formulations, and mechanisms in management of gingivitis. IL: interleukin, IFN: interferon, GI: gingivitis index, PI: plaque index, BOP: bleeding on probing index, PPD: periodontal pocket depth